Sort by
Keyphrases
Cataract Surgery
21%
Cellularity
21%
Complication Outcome
14%
Cryotherapy
21%
Early Surgery
29%
Epiretinal Membrane
27%
Fellow Eye
15%
Floaters
43%
Forceps
32%
Germline mutation
14%
Hyalocytes
26%
Internal Limiting Membrane
17%
Intravitreal Dexamethasone
14%
Juxtapapillary
29%
Laser Photocoagulation
20%
Laser Therapy
17%
Late Development
16%
Mutation Carriers
14%
Ocular Toxicity Studies
14%
Pathophysiology
17%
Pediatric Patients
14%
Posterior Vitreous Detachment
51%
Proliferative Vitreoretinopathy
71%
Prophylactic Laser
14%
Rabbit Eye
14%
Randomized Placebo-controlled Trial
14%
Retina
24%
Retinal Break
29%
Retinal Detachment
47%
Retinal Detachment Surgery
19%
Retinal Hemangioblastoma
89%
Retinal Surfaces
31%
Retinal Tear
41%
Retinal Vein
18%
Rhegmatogenous Retinal Detachment
39%
Superiority Trial
14%
Surgical Technique
21%
Surgical Treatment
21%
Symptom Awareness
14%
Treatment Options
27%
Treatment Outcome
14%
Trypan Blue
28%
Visual Acuity
33%
Visual Outcome
21%
Vitrectomy
53%
Vitreoretinal Surgery
31%
Vitreoschisis-induced Vitreous Cortex Remnants
42%
Vitreous Cortex Remnants
58%
Vitreous Hemorrhage
26%
Von Hippel-Lindau
16%
Medicine and Dentistry
Agents Acting on the Eye
14%
Alteplase
11%
Antibiotics
14%
Best Corrected Visual Acuity
10%
Cannulation
22%
Cataract Surgery
22%
Central Retinal Vein Occlusion
14%
Cryotherapy
21%
Dexamethasone
14%
Diathermy
29%
Endophthalmitis
14%
Epiretinal Membrane
31%
Ex Vivo
14%
Eye Toxicity
14%
Flushing
30%
Glaucoma
14%
Hamartoma
14%
Hemangioblastoma
74%
Histopathology
14%
Implant
14%
Laser Coagulation
24%
Low Level Laser Therapy
17%
Neoplasm
12%
Optical Coherence Tomography Angiography
14%
Pathophysiology
17%
Pediatrics Patient
14%
Placebo
14%
Pooled Analysis
12%
Posterior Vitreous Detachment
57%
Prevalence
14%
Proliferative Vitreoretinopathy
81%
Randomized Clinical Trial
14%
Retina Tear
46%
Retinal Break
29%
Retinal Detachment
74%
Retinal Haemorrhage
13%
Retinal Pigment Epithelium
14%
Retinopexy
14%
Surgery
34%
Surgical Technique
15%
Symptom
44%
Systematic Review
29%
Tissue Plasminogen Activator
14%
Trypan Blue
31%
Visual Acuity
32%
Visual Impairment
14%
Vitrectomy
54%
Vitreoretinal Surgery
28%
Vitreous
100%
Vitreous Hemorrhage
38%